Partnering key to Takeda's lofty goals for new vaccines division
This article was originally published in Scrip
Executive Summary
Takeda has laid out ambitious targets for its new vaccines division, saying that it is looking to secure a global top five position as a supplier of such products to developed markets by the end of the decade.